The Botulinum Toxin-coated Microneedles segmentation by application can be delineated into three primary sub‑segments: Cosmetic, Therapeutic, and Dermatology. The Cosmetic sub‑segment, encompassing wrinkle‑reduction and facial contouring, commands the largest share of the market, driven by high consumer demand for minimally invasive aesthetic procedures and premium pricing structures. The Therapeutic sub‑segment includes indications such as hyperhidrosis, focal spasticity, and neuropathic pain, where the precise intradermal delivery of botulinum toxin offers clinical advantages over traditional injection methods, contributing a substantial portion of revenue through hospital and specialty clinic adoption. The Dermatology sub‑segment covers scar remodeling, pigmentary disorders, and acne treatment, representing a niche yet growing area as dermatologists seek targeted delivery platforms to enhance efficacy and reduce systemic exposure. Collectively, these application categories shape the overall market size by allocating resources, R&D focus, and commercial strategies according to their relative market penetration and growth trajectories.